These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 26683882)

  • 1. Is acute stress and plasminogen activator inhibitor polymorphism associated with acute ischemic stroke?
    Kozak HH; Uca AU; Altaş M
    Clin Neurol Neurosurg; 2016 Apr; 143():159-60. PubMed ID: 26683882
    [No Abstract]   [Full Text] [Related]  

  • 2. The plasminogen activator inhibitor-1 gene polymorphism in determining the risk of pediatric ischemic stroke--case control and family-based study.
    Balcerzyk A; Żak I; Emich-Widera E; Kopyta I; Iwanicki T; Pilarska E; Pienczk-Ręcławowicz K; Kaciński M; Wendorff J; Połatyńska K
    Neuropediatrics; 2011 Feb; 42(2):67-70. PubMed ID: 21647848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GLU298ASP and 4G/5G Polymorphisms and the Risk of Ischemic Stroke in Young Individuals.
    Esparza-García JC; Santiago-Germán D; Guadalupe Valades-Mejía M; Hernández-Juárez J; Aguilar-Sosa E; Leaños-Miranda A; Alvarado-Moreno A; Majluf-Cruz A; Isordia-Salas I
    Can J Neurol Sci; 2015 Sep; 42(5):310-6. PubMed ID: 26036781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The plasminogen activator inhibitor (PAI-1) 4G/5G promoter polymorphism and PAI-1 levels in ischemic stroke. A case-control study.
    van Goor ML; Gómez García E; Leebeek F; Brouwers GJ; Koudstaal P; Dippel D
    Thromb Haemost; 2005 Jan; 93(1):92-6. PubMed ID: 15630497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gorlin-Goltz syndrome and stroke: a case report.
    Budinčević H; Starčević K; Bielen I; Demarin V
    Acta Dermatovenerol Croat; 2014; 22(3):209-12. PubMed ID: 25230063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of stroke: replicated findings in two nested case-control studies based on independent cohorts.
    Wiklund PG; Nilsson L; Ardnor SN; Eriksson P; Johansson L; Stegmayr B; Hamsten A; Holmberg D; Asplund K
    Stroke; 2005 Aug; 36(8):1661-5. PubMed ID: 16020771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinolytic gene polymorphism and ischemic stroke.
    Jood K; Ladenvall P; Tjärnlund-Wolf A; Ladenvall C; Andersson M; Nilsson S; Blomstrand C; Jern C
    Stroke; 2005 Oct; 36(10):2077-81. PubMed ID: 16179568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of the plasminogen activator inhibitor-1 4G/5G polymorphism on the thrombotic risk.
    Tsantes AE; Nikolopoulos GK; Bagos PG; Bonovas S; Kopterides P; Vaiopoulos G
    Thromb Res; 2008; 122(6):736-42. PubMed ID: 17949795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of association between plasminogen activator inhibitor type-1 (PAI-1) gene 4G/5G polymorphism frequency and plasma PAI-1 enzyme activity in patients with acute stroke.
    Kucukarabaci B; Gunes HV; Ozdemir G; Cosan D; Ozbabalik D; Dikmen M; Degirmenci I
    Genet Test; 2008 Sep; 12(3):443-51. PubMed ID: 18662099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis association of acute ischemic stroke and DNA markers in Russian and Moldavian populations].
    Bondarenko EA; Shetova IM; Shamalov NA; Mokan EI; Barbakar NI; Kurochkin GS; Protopop SS; Lysyĭ LT; SlominskIĭ PA; Limborskaia SA; Skvortsova VI
    Genetika; 2011 Oct; 47(10):1393-401. PubMed ID: 22232928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAI-1 4G/5G polymorphism is associated with brain vessel reocclusion after successful fibrinolytic therapy in ischemic stroke patients.
    Fernandez-Cadenas I; Del Rio-Espinola A; Rubiera M; Mendioroz M; Domingues-Montanari S; Cuadrado E; Hernandez-Guillamon M; Rosell A; Ribo M; Alvarez-Sabin J; Molina CA; Montaner J
    Int J Neurosci; 2010 Apr; 120(4):245-51. PubMed ID: 20374070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator inhibitor type 1 gene polymorphisms and haplotypes are associated with plasma plasminogen activator inhibitor type 1 levels but not with myocardial infarction or stroke.
    Ding J; Nicklas BJ; Fallin MD; de Rekeneire N; Kritchevsky SB; Pahor M; Rodondi N; Li R; Zmuda JM; Harris TB
    Am Heart J; 2006 Dec; 152(6):1109-15. PubMed ID: 17161063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A-G-4G haplotype of PAI-1 gene polymorphisms -844 G/A, HindIII G/C, and -675 4G/5G is associated with increased risk of ischemic stroke caused by small vessel disease.
    Adamski MG; Turaj W; Slowik A; Wloch-Kopec D; Wolkow P; Szczudlik A
    Acta Neurol Scand; 2009 Aug; 120(2):94-100. PubMed ID: 19154538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4G/4G genotype of PAI-1 gene is associated with reduced risk of stroke in elderly.
    Hoekstra T; Geleijnse JM; Kluft C; Giltay EJ; Kok FJ; Schouten EG
    Stroke; 2003 Dec; 34(12):2822-8. PubMed ID: 14605330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 gene polymorphisms on tissue-type plasminogen activator-induced recanalization in ischemic stroke patients.
    Fernandez-Cadenas I; Alvarez-Sabin J; Ribo M; Rubiera M; Mendioroz M; Molina CA; Rosell A; Montaner J
    J Thromb Haemost; 2007 Sep; 5(9):1862-8. PubMed ID: 17723126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism in the P-selectin and interleukin-4 genes as determinants of stroke: a population-based, prospective genetic analysis.
    Zee RY; Cook NR; Cheng S; Reynolds R; Erlich HA; Lindpaintner K; Ridker PM
    Hum Mol Genet; 2004 Feb; 13(4):389-96. PubMed ID: 14681304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of genetic variants of fibrinolytic system with stroke and stroke subtypes.
    Babu MS; Prabha TS; Kaul S; Al-Hazzani A; Shafi G; Roy S; Balakrishna N; Jyothy A; Munshi A
    Gene; 2012 Mar; 495(1):76-80. PubMed ID: 22240314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of PAI-1 4G/5G and -844G/A gene polymorphism and changes in PAI-1/tPA levels in stroke: a case-control study.
    Saidi S; Slamia LB; Mahjoub T; Ammou SB; Almawi WY
    J Stroke Cerebrovasc Dis; 2007; 16(4):153-9. PubMed ID: 17689411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of COX-2 rs5275 and rs20417 and GPIIIa rs5918 polymorphisms on 90-day ischemic stroke functional outcome: a novel finding.
    Maguire J; Thakkinstian A; Levi C; Lincz L; Bisset L; Sturm J; Scott R; Whyte S; Attia J
    J Stroke Cerebrovasc Dis; 2011; 20(2):134-44. PubMed ID: 20472470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 4G/4G plasminogen activator inhibitor-1 genotype is associated with frequent recurrence of acute otitis media.
    Emonts M; Wiertsema SP; Veenhoven RH; Houwing-Duistermaat JJ; Walraven V; de Groot R; Hermans PW; Sanders EA
    Pediatrics; 2007 Aug; 120(2):e317-23. PubMed ID: 17671042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.